Brief: Dri Healthcare Trust Says Approval Of Pacritinib By FDA Is Condition To Acquisition Of Tiered Royalty On Pacritinib
Nov 30 (Reuters) - CTI Biopharma Corp CTIC.O :
* DRI HEALTHCARE TRUST - APPROVAL OF PACRITINIB BY FDA IS
CONDITION TO ACQUISITION OF TIERED ROYALTY ON PACRITINIB, AS
ANNOUNCED ON AUGUST 25, 2021
Source text for Eikon: ID:nCNW5QW0Za
Further company coverage: CTIC.O
Recent news on DRI Healthcare Trust
See all newsCanada's DRI Healthcare Trust Q1 total income rises
Brief: DRI Healthcare Trust Q1 Total Income USD 50.561 Million
Canada's DRI Healthcare annual income hits record, raises distribution
Brief: DRI Healthcare Trust Q4 Total Income USD 61.686 Million
Brief: Dri Healthcare Trust Announces Preferred Securities Refinancing